Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease
Clinical trial NCT00462189 · UNKNOWN
Trial details
- NCT number
- NCT00462189
- Sponsor
- Cambridge Antibody Technology
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.